Research graph
References from Patient Safety Gaps in Rheumatology: A Mixed-Methods Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Correction to: hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
10.1007/s00296-017-3918-8 · 2018 · External reference
Gaps in ambulatory patient safety for immunosuppressive specialty medications
2019 · External reference
Effect of early treatment with disease-modifying anti-rheumatic drugs and treatment adherence on disease outcome in rheumatoid arthritis patients
10.1016/j.ejr.2016.11.004 · 2017 · External reference
Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice
10.1007/s10067-005-0155-4 · 2006 · External reference
Quality-of-life assessment in rheumatoid arthritis
10.2165/00019053-200826100-00004 · 2008 · External reference
Quality of care for patients with systemic lupus erythematosus: data from the American College of Rheumatology RISE registry
10.1002/acr.24446 · 2022 · External reference
Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients
10.1093/ndt/gfx048 · 2017 · External reference
2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
10.1002/acr.24596 · 2021 · External reference
Development of the American College of Rheumatology’s rheumatoid arthritis electronic clinical quality measures
10.1002/acr.22984 · 2016 · External reference
Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab
10.1097/md.0000000000006528 · 2017 · External reference
Screening for latent infections among users of high-risk immunosuppressants: a cross-sectional analysis from the Veterans Health Administration healthcare system
10.1097/pts.0000000000001079 · 2023 · External reference
RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs
10.1016/j.semarthrit.2020.03.003 · 2020 · External reference
Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
10.1177/1759720x20930116 · 2020 · External reference
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression: risks, screening, diagnosis and management
10.1111/apt.16952 · 2022 · External reference
Biologics and tuberculosis preventive therapy
10.59556/japi.73.0847 · 2025 · External reference
Latent tuberculosis screening among new users of a biologic or targeted synthetic disease-modifying antirheumatic drug: gaps in screening overall and among janus kinase inhibitors
10.1002/acr.25318 · 2024 · External reference
Adherence to hydroxychloroquine dosing guidelines by rheumatologists: an electronic medical record-based study in an integrated health care system
10.1016/j.ophtha.2016.12.021 · 2017 · External reference
Case report: hydroxychloroquine retinopathy
10.1097/opx.0000000000001226 · 2018 · External reference
Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
10.1007/s00296-017-3782-6 · 2017 · External reference
Osteoporosis: evaluation of screening patterns in a primary-care group practice
10.1016/j.jocd.2008.08.104 · 2008 · External reference
Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study
10.1007/s11606-015-3349-8 · 2015 · External reference
Trends and determinants of osteoporosis treatment and screening in patients with rheumatoid arthritis compared to osteoarthritis
10.1002/acr.23331 · 2018 · External reference
Utilization of preventive services in a systemic lupus erythematosus population-based cohort
2022 · External reference
Integration through connecting in explanatory sequential mixed method studies
10.1177/0193945920914647 · 2020 · External reference
Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
10.1186/1748-5908-4-50 · 2009 · External reference
Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation
10.1186/s13012-017-0550-7 · 2017 · External reference
Development and formative evaluation of the e-Health Implementation Toolkit (e-HIT)
10.1186/1472-6947-10-61 · 2010 · External reference
Qualitative content analysis in nursing research: concepts, procedures, and measures to achieve trustworthiness
10.1016/j.nedt.2003.10.001 · 2004 · External reference
Creating a toolkit to reduce disparities in patient engagement
10.1097/mlr.0000000000000748 · 2017 · External reference
Promoting student belongingness: ‘WANTED’-the development, implementation and evaluation of a toolkit for nurses
10.37464/2017.343.1525 · 2017 · External reference
Implementing electronic patient-reported outcomes measurements: challenges and success factors
10.1136/bmjqs-2018-008426 · 2018 · External reference
Organizational capacity for change in health care: Development and validation of a scale
10.1097/hmr.0000000000000096 · 2017 · External reference
Leveraging the consolidated framework for implementation research to develop the American College of Rheumatology’s toolkit for implementation of rheumatoid arthritis outcome measures in clinical practice: a qualitative study
10.1002/acr.25410 · 2024 · External reference
A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice
10.1186/1748-5908-8-35 · 2013 · External reference
Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews
10.1136/bmjopen-2022-062158 · 2023 · External reference
Social support and patient adherence to medical treatment: a meta-analysis
10.1037/0278-6133.23.2.207 · 2004 · External reference
Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis
10.1016/j.pec.2016.01.020 · 2016 · External reference
Development of the American College of Rheumatology’s rheumatoid arthritis electronic clinical quality measures
10.1002/acr.22984 · ExternalCitation · doi-reference
Trends and determinants of osteoporosis treatment and screening in patients with rheumatoid arthritis compared to osteoarthritis
10.1002/acr.23331 · ExternalCitation · doi-reference
Quality of care for patients with systemic lupus erythematosus: data from the American College of Rheumatology RISE registry
10.1002/acr.24446 · ExternalCitation · doi-reference
2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
10.1002/acr.24596 · ExternalCitation · doi-reference
Latent tuberculosis screening among new users of a biologic or targeted synthetic disease-modifying antirheumatic drug: gaps in screening overall and among janus kinase inhibitors
10.1002/acr.25318 · ExternalCitation · doi-reference
Leveraging the consolidated framework for implementation research to develop the American College of Rheumatology’s toolkit for implementation of rheumatoid arthritis outcome measures in clinical practice: a qualitative study
10.1002/acr.25410 · ExternalCitation · doi-reference
Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
10.1007/s00296-017-3782-6 · ExternalCitation · doi-reference
Correction to: hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
10.1007/s00296-017-3918-8 · ExternalCitation · doi-reference
Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice
10.1007/s10067-005-0155-4 · ExternalCitation · doi-reference
Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study
10.1007/s11606-015-3349-8 · ExternalCitation · doi-reference
Effect of early treatment with disease-modifying anti-rheumatic drugs and treatment adherence on disease outcome in rheumatoid arthritis patients
10.1016/j.ejr.2016.11.004 · ExternalCitation · doi-reference
Osteoporosis: evaluation of screening patterns in a primary-care group practice
10.1016/j.jocd.2008.08.104 · ExternalCitation · doi-reference
Qualitative content analysis in nursing research: concepts, procedures, and measures to achieve trustworthiness
10.1016/j.nedt.2003.10.001 · ExternalCitation · doi-reference
Adherence to hydroxychloroquine dosing guidelines by rheumatologists: an electronic medical record-based study in an integrated health care system
10.1016/j.ophtha.2016.12.021 · ExternalCitation · doi-reference
Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis
10.1016/j.pec.2016.01.020 · ExternalCitation · doi-reference
RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs
10.1016/j.semarthrit.2020.03.003 · ExternalCitation · doi-reference
Social support and patient adherence to medical treatment: a meta-analysis
10.1037/0278-6133.23.2.207 · ExternalCitation · doi-reference
Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients
10.1093/ndt/gfx048 · ExternalCitation · doi-reference
Organizational capacity for change in health care: Development and validation of a scale
10.1097/hmr.0000000000000096 · ExternalCitation · doi-reference
Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab
10.1097/md.0000000000006528 · ExternalCitation · doi-reference
Creating a toolkit to reduce disparities in patient engagement
10.1097/mlr.0000000000000748 · ExternalCitation · doi-reference
Case report: hydroxychloroquine retinopathy
10.1097/opx.0000000000001226 · ExternalCitation · doi-reference
Screening for latent infections among users of high-risk immunosuppressants: a cross-sectional analysis from the Veterans Health Administration healthcare system
10.1097/pts.0000000000001079 · ExternalCitation · doi-reference
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression: risks, screening, diagnosis and management
10.1111/apt.16952 · ExternalCitation · doi-reference
Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews
10.1136/bmjopen-2022-062158 · ExternalCitation · doi-reference
Implementing electronic patient-reported outcomes measurements: challenges and success factors
10.1136/bmjqs-2018-008426 · ExternalCitation · doi-reference
Integration through connecting in explanatory sequential mixed method studies
10.1177/0193945920914647 · ExternalCitation · doi-reference
Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
10.1177/1759720x20930116 · ExternalCitation · doi-reference
Development and formative evaluation of the e-Health Implementation Toolkit (e-HIT)
10.1186/1472-6947-10-61 · ExternalCitation · doi-reference
Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
10.1186/1748-5908-4-50 · ExternalCitation · doi-reference
A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice
10.1186/1748-5908-8-35 · ExternalCitation · doi-reference
Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation
10.1186/s13012-017-0550-7 · ExternalCitation · doi-reference
Quality-of-life assessment in rheumatoid arthritis
10.2165/00019053-200826100-00004 · ExternalCitation · doi-reference
Promoting student belongingness: ‘WANTED’-the development, implementation and evaluation of a toolkit for nurses
10.37464/2017.343.1525 · ExternalCitation · doi-reference
Biologics and tuberculosis preventive therapy
10.59556/japi.73.0847 · ExternalCitation · doi-reference